Background: Dopamine is an inotropic agent that is often selected for continuous infusion. For hemodynamic stability, the rate of infusion is controlled in the range of 5-15 μg/kg/min. This study aimed to compare the time intervals from the administration of dopamine to the onset of its hemodynamic effects when dopamine was administered through three different peripheral veins (the cephalic vein [CV], the great saphenous vein [GSV], and the external jugular vein [EJV]). Methods: Patients in group 1, group 2, and group 3 received dopamine infusions in the CV, GSV, and EJV, respectively. A noninvasive continuous cardiac output monitor (NICCOMO™, Medis, Ilmenau, Germany) was used to assess cardiac output (CO) and systemic vascular resistance (SVR). Six minutes after intubation, baseline heart rate (HR), systolic blood pressure (BP), diastolic BP, mean arterial pressure (MAP), CO, and SVR values were recorded and dopamine infusion was initiated at a dose of 10 μg/kg/min. Hemodynamic changes at 0, 4, 8, 12, and 15 minutes postinfusion were recorded. Results: No statistically significant differences were observed among the three groups with respect to the rate of hemodynamic change. In all groups, systolic BP, diastolic BP, MAP, and SVR tended to increase after decreasing for the first 4 minutes; in contrast, HR and CO decreased until 8 minutes, after which they tended to reach a plateau. Conclusions: For patients under general anesthesia receiving dopamine at 10 μg/kg/min, there were no clinical differences in the effect of dopamine administered through three different peripheral veins.
Introduction
Hypotension is common during induction and maintenance of general anesthesia. This condition can be caused by inhibition of central nervous system activation [1] , surgical bleeding, or weakened compensation mechanisms from the effects of anesthesia. Inotropic agents can be used to treat hypotension and achieve hemodynamic stability [2] . However, if the effect of the inotropes is delayed, the risk of cardiovascular collapse may be increased. Dopamine is an inotropic agent that is often used for continuous infusion. To achieve hemodynamic stability, the infusion rate is controlled in the range of 5-15 μg/kg/min [2] .
To administrate fluids or drugs during anesthesia, intravenous routes should be secured at the patient's extremities or cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. neck. One study performed in a canine model found that circulation time after central venous injection was significantly shorter than that after peripheral venous injection during cardiac arrest [3] . The authors hypothesized that dopamine would exert its effects more rapidly in the central veins. We set out to determine whether the latency times from dopamine administration to the beginning of the hemodynamic effect differed among patients given dopamine via three different veins, the cephalic vein (CV), the great saphenous vein (GSV), and the external jugular vein (EJV). We reasoned that, if such a difference existed, this information would be an important consideration in an emergency situation.
Here we evaluated the time intervals from the administration of dopamine to the onset of the hemodynamic effect after dopamine administration via different routes.
Materials and Methods
This study was conducted at a single center (Chonbuk National University Hospital). 
Results
There were 19, 19, and 22 patients in the CV, GSV, and EJV groups, respectively ( Table 1 ). All patients met the blood pressure criteria for proceeding with the study, and dopamine infusion was initiated 6 minutes after intubation for all subjects. For 2 patients in the EJV group, the study was discontinued due to high systolic BP (more than 180 mmHg) or rapid HR (over 120 beats per minute). These patients were provided proper management and excluded from the analysis. No significant differences were observed among the three groups for any of the demographic characteristics recorded. No patient had any underlying disease, with the exception of well controlled or uncomplicated diabetes mellitus.
No significant differences were observed with respect to hemodynamic baseline values among the three groups (Table 2) . Similarly, no significant differences were observed with respect to hemodynamic changes among the three groups (Figure 1) . Overall, systolic BP, diastolic BP, MAP, and SVR tended to increase after decreasing for the first 4 minutes in all three groups; moreover, these values increased significantly from 12 minutes onward.
In contrast, HR and CO decreased until 8 minutes postin- The values are expressed as mean ± SD. There were no significant differences for hemodynamic baseline values among the three groups. CV: cephalic vein; GSV: great saphenous vein; EJV: external jugular vein; BP: blood pressure; MAP: mean arterial pressure: HR: heart rate; CO: cardiac output; SVR: systemic vascular resistance.
fusion, at which point the values tended to plateau. The hemodynamic parameters were significantly different by two-way RM ANOVA within each group. P-values reflecting the significance of differences between observation time points are presented in Table 3 . 
Discussion
Here we investigated whether the latency times from dopamine administration to the onset of hemodynamic effects differed in patients given dopamine via three different veins (cephalic, great saphenous, and external jugular). We did not observe any differences in the latency periods from dopamine administration to hemodynamic effect onset among the different dopamine administration routes. We speculate that the hemodynamic effect of dopamine is not affected by administration route in the normal circulatory state or in the shock state. Although we did not observe any significant differences among the three groups in terms of hemodynamic changes, overall BP, systolic BP, diastolic BP, MAP, and SVR tended to increase after decreasing for 4 minutes in all groups.
Moreover, these parameters all increased significantly shock reported that cardiac function was improved when dopamine was used [4] . When exogenous dopamine is infused, its pharmacodynamic effects are well correlated with the rate of infusion. Specifically, dopamine has been shown to stimulate β-adrenergic receptors at intermediate doses (3-10 μg/kg/min) and α-adrenergic receptors at higher doses (> 10 μg/kg/min) [2, 5] . β 1 receptors predominate in cardiac smooth muscle cells, whereas α 1 receptors predominate in arterial smooth muscles. β 1 receptors act on the sinoatrial node to produce positive chronotropy and on the atrial or ventricular muscle to produce inotropy [6] .
These receptors ameliorate HR (chronotropy) and cardiac contractility (inotropy) to maintain stroke volume and CO at a biological set point [7] . Therefore, we selected the highest possible intermediate dopamine dose (10 μg/kg/ min) with the goal of observing a distinct reaction of β 1 -adrenergic receptors. However, we did not observe any increase in HR or CO.
Considerable interpatient variability has been observed in dopamine pharmacokinetics, even in homogeneous populations of healthy volunteers [8, 9] . Moderate doses of dopamine are thought to maximize inotropy and avoid excessive α-adrenergic stimulation. However, definitive evidence supporting the use of dopamine in this setting is lacking. In another study, the breakpoint for a reduction in cardiac index and an increase in systemic vascular resistance index occurred at an infusion rate of approximately 15 mg/kg/min [9] . Dopamine infused at a rate close to 10 μg/kg/min was shown to exert a positive effect on CO, whereas heart rate and arterial pressure barely changed [4] . High ''vasopressor'' doses of dopamine (> 10 mg/kg/min) increase α 1 receptor signaling and thus increase MAP activation by progressively increasing SVR without further increasing CO [10] . In our study, although we did not observe a clear trend of increased CO, BP was observed to increase as SVR increased. We reason that an increase in CO was not observed because HR did not increase.
Two minutes after the beginning of dopamine infusion, plasma dopamine levels were significantly elevated compared with baseline, and dopamine approached a steadystate level within 30 min [11] . In one previous study, the plasma concentration of dopamine was shown to reach a steady state after 5 minutes of intravenous infusion [12] .
We observed that systolic BP, diastolic BP, MAP, and SVR all tended to increase (after decreasing for the first 4 minutes) in all groups.
The major cause of cardiovascular response during intubation is tissue tension induced by the laryngoscopic blade in the supraglottic region [13] . The pressor response to laryngoscopy and intubation is mediated via sympathetic nerves [14] . Significant increases in mean arterial pressure have been noted 1 min after intubation, with mean arterial pressure returning to baseline values (i.e., preanesthesia) after about 5 minutes [15] . Dopamine infusion was started at 7 minutes after intubation in this study.
Dopamine has major side effects such as severe hypertension, ventricular arrhythmias, and cardiac ischemia.
Severe hypertension and tachycardia occurred in two patients in our study. Appropriate management was provided for these patients, and the complications did not recur.
There is one particularly important limitation to our study. The effect of general anesthesia on circulation is more complex than our study setting was able to account
for. In addition to their sympathovagal effects, general anesthetics (including propofol) have negative inotropic effects on the heart and direct vasodilatory effects. The hemodynamic changes caused by dopamine infusion may thus be blunted when the patient is in an anesthetized state. Some patients took nonsteroidal anti-inflammatory drugs (NSAIDs) prior to surgery. Prostacyclin (PGI 2 ) is a vasodilator that is synthesized in endothelial cells, primarily by a Cyclooxygenases-2-dependent pathway.
Treatment with NSAIDs may inhibit production of PGI 2 and reduce PG-mediated inhibition of endothelin-1 production, resulting in increased peripheral resistance [16] .
Hemodynamic changes caused by dopamine infusion in patients with NSAIDs may also be blunted. However, it is challenging to determine the precise effect of NSAIDs on these hemodynamic changes.
In summary, we did not observe any differences in the time dopamine took to affect patients under general anesthesia when dopamine was infused at a rate of 10 μg/kg/min.
